More Business Wire
View Older Stories View Newer Stories-
Global Seagate Research Finds Nearly All Organizations Expect AI to Increase Storage Requirements, but Only 38% of Organizations Say They Are Fully Prepared
-
Everspin Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
-
EBG Celebrates 25 Years of Connecting Millions of Consumers to Unforgettable Experiences and Everyday Value
-
Citrix Co-President Hector Lima to speak at WSJ Technology Council Summit
-
Definium Therapeutics Announces New Employee Inducement Grants
-
Airrived Launches Agentic Observability, Giving Enterprises Real-Time Visibility and Control Over Every AI Agent Decision
-
WisdomTree Reports Monthly Metrics for August 2026
-
The Indigenomics Institute Hosts its 3rd Global Indigenous Economic Forum
-
SoClean Launches National TV Campaign to Reach Millions of CPAP Users
-
Artisight Acquires TMG Global to Accelerate Smart Hospital Deployments Across U.S. Health Systems
-
Expo 2030 Riyadh and Mohammed Al Habib Real Estate Company Sign a 3.2 billion SAR Joint Venture Agreement to Develop and Deliver Expo Village
-
Ferguson’s Family of Farms Introduces Community Harvest Days, Giving Back to Local Organizations Across Minnesota and Wisconsin
-
Motive Announces Entitlement Server General Availability for iPhone Duo, iPhone 18 Pro and iPhone 18 Pro Max
-
Havas Reports the Progress of Transactions Under Its Current Share Buyback Program
-
Venture Global and China Gas Announce New Long-Term LNG Agreement
-
ATP Media & L1VE Agree Landmark Immersive Rights Partnership
-
Appleby to Accelerate Growth in Legal and Fiduciary Services With Investment From New Mountain Capital
-
Omdia: Global Semiconductor Revenue Surges 31% to Record $425bn in 2Q26
-
Alpine Launches UK Hard Facilities Management Platform, Eight Group Service Partners
-
Nano One Selected for Inaugural Canada Investment Summit 2026
-
U.S. FDA Accepts New Drug Application Under Priority Review for Takeda’s Zasocitinib in Moderate-to-Severe Plaque Psoriasis, with Potential to Redefine Oral Treatment Expectations
-
SWISSto12 and Mitsubishi Electric Corporation Announce Strategic Partnership
-
Patch My PC Launches Security Application for Risk-Based Vulnerability Prioritization and Remediation Tracking
-
BlackSky’s Fifth Gen-3 Attains First Light in Hours, Expanding Constellation Capacity and Decision-Making Speed for Customers
-
Palliser Capital Issues Letter to Recordati’s Board of Directors Urging Withdrawal of Support on Materially Undervalued Tender Offer
-
Hoffmann Green Continues to Diversify Its Markets With the Signing of a Partnership With Terrena, a Leading Agricultural Cooperative Group in Western France
-
Jaggaer Completes Acquisition of Ivoflow, Bringing AI-Powered Direct Materials Spend & Price Intelligence to Manufacturers
-
Focused Support Launches Cavok STRIKE to Expand Link-16 Participation Across the Joint Force
-
MEX Exchange, Part of MultiBank Group, Expands Executive Team as International Growth Accelerates
-
Fujirebio Expands Access to Blood-based Neurology Testing in Brazil with ANVISA Market Authorization for Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma
-
Neat and Zoho Cliq Come Together to Enhance Meeting Room Experiences for Businesses
-
Volkswagen Ranked Highest in 2026 Auto Industry Service Scheduling Effectiveness™ Study
-
Signaloid Announces Appointment of Quantitative Finance and Cloud Veterans to Advisory Board and Senior Commercialization Roles
-
Mitsubishi Electric’s New Plate Heat Exchanger Delivers 3x Conventional Heat Transfer Performance
-
ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in DESTI
-
TAGRISSO® (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial
-
Enhertu® Demonstrated a Median Progression-Free Survival of 14.3 Months as First-Line Therapy in Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer in DESTINY-Lung04 Phase 3 Trial
-
Black & Veatch celebrates more than fifteen years of FLNG innovation, engineering experience and advancement of PRICO liquefaction performance at Gastech 2026
-
Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median Progression-Free Survival Benefit in REZILIENT3 Phase 3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
-
Corgan Expands Aviation Practice in Asia Pacific with Ben Dawson Hire
-
Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Previews the Upcoming 9/19 Event; Highlights FF’s EAI Robotics' Autonomous Perception and 3D Scanning Technology; Adds a N
-
Definium Therapeutics to Discuss Topline Results from Phase 3 Panorama Study in Generalized Anxiety Disorder on September 14, 2026
-
SES’s Final Three O3b mPOWER Satellites Successfully Launched
-
Wild Alaskan Company - Hits Shelves with Nationwide Target Launch
-
Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso’s HARMONi-2 Study
-
Glenfarne Group Promotes Oliver Wood to Global Head of Projects
-
Aster Guardians Global Nursing Award 2026 Names Agimol Pradeep From United Kingdom Winner of USD 250,000 Prize
-
Calvin Klein Collection by Veronica Leoni Spring 2027 Runway Show Presented in New York City
-
Truck Drivers Say: “Minister Hajdu: It’s time to take on bad bosses, enforce the Canada Labour Code, and invest in road health and safety.”
-
SIV Ambulances Enters Ambulance Manufacturing with Launch of SIV Responder and Responder XL Type II Ambulances
